Doria, A., Bass, D., Schwarting, A., Hammer, A., Gordon, D., Scheinberg, M., . . . Roth, D. (2018). A 6-month open-label extension study of the safety and efficacy of subcutaneous belimumab in patients with systemic lupus erythematosus. Lupus.
Style de citation ChicagoDoria, A., et al. "A 6-month Open-label Extension Study of the Safety and Efficacy of Subcutaneous Belimumab in Patients With Systemic Lupus Erythematosus." Lupus 2018.
Style de citation MLADoria, A., et al. "A 6-month Open-label Extension Study of the Safety and Efficacy of Subcutaneous Belimumab in Patients With Systemic Lupus Erythematosus." Lupus 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.